Encodia is a series c plus startup based in United States. 2 investors tracked.
Encodia is a company headquartered in the United States. Encodia has been acquired. Brouky records 3 investors associated with the company.
Encodia develops a digital proteomics platform using reverse-translation technology to convert peptide sequences into DNA for large-scale protein sequencing, enabling breakthrough insights into cellular processes and advancing personalized medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.